Showing results (441-450 of 786) with videos related to

Sort By:
Pageof 79
In Silico Pharmacology|July 29, 2025
The inhibitory effects of Centella asiatica compounds on myeloid cell leukemia 1 (MCL-1) in cancer: a computational studyCecilia Oluwamodupe, Olorunfemi Oyewole Babalola, Paul Olamide Ottu, et al.
In Silico Pharmacology|September 30, 2014
Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti -tuberculosis therapyKuteesa R Bisaso, Joel S Owen, Francis W Ojara, et al.
In Silico Pharmacology|November 1, 2017
Novel dihydropyrimidine derivatives as potential HDAC inhibitors: in silico studyGanapathi Thipparapu, Rajanna Ajumeera, Vijayalakshmi Venkatesan
In Silico Pharmacology|July 9, 2016
Classification model of amino acid sequences prone to aggregation of therapeutic proteinsMonika Marczak, Krystyna Okoniewska, Tomasz Grabowski
In Silico Pharmacology|September 20, 2017
Computational approaches to the in vitro antibacterial activity of Allium hirtifolium Boiss against gentamicin-resistant Escherichia coli: focus on ribosome recycling factorSakar Emad Ali, Khosrow Chehri, Nasser Karimi, et al.
In Silico Pharmacology|June 25, 2021
Structure based design, stability study and synthesis of the dinitrophenylhydrazone derivative of the oxidation product of lanosterol as a potential P. falciparum transketolase inhibitor and in-vivo antimalarial studyOlatomide A Fadare, Nusrat O Omisore, Oluwaseun B Adegbite, et al.
In Silico Pharmacology|November 28, 2022
Structural insight and analysis of TLR4 interactions with IAXO-102, TAK-242 and SN-38: an in silico approachJanine S Y Tam, Jinxin V Pei, Janet K Coller, et al.
In Silico Pharmacology|June 8, 2022
Investigation of the mechanism of Shen Qi Wan prescription in the treatment of T2DM via network pharmacology and molecular dockingPiaopiao Zhao, Xiaoxiao Zhang, Yuning Gong, et al.
In Silico Pharmacology|May 11, 2022
Theoretical modeling and design of some pyrazolopyrimidine derivatives as Wolbachia inhibitors, targeting lymphatic filariasis and onchocerciasisFabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu, et al.
In Silico Pharmacology|July 8, 2022
Khaya grandifoliola active fraction as a source of therapeutic compounds for Alzheimer's disease treatment: In silico validation of identified compoundsBrice Ayissi Owona, Frederic N Njayou, Pierre Mkounga, et al.
Pageof 79